After adjusting for gender, anti-FadAc IgA levels remain significantly higher in colorectal cancer compared with the advanced adenoma group (estimate = 0.592 μg/mL, SE = 0.262, P = 0.026). This evidence concerns the gene CD79A and colorectal cancer.